Digital Health has been a hot market space in recent times with investors collectively pouring $26 billion since 2010 and over $7.2 billion just last year.  Mobile health or mHealth apps were seen as a crucial element in managing chronic conditions like diabetes and asthma, by helping patients take care of their lifestyle and medications.  In fact, mHealth Apps were the largest funded category in digital health, with over 325,000 apps available by end of 2017.   

According to the National Assessment of Adult Literacy, only 12 percent of adults in the U.S. have proficient health literacy. In terms of numbers, that is nine out of ten adults who lack the skills needed to manage their health and prevent disease. Low literacy has been linked to poor health outcomes such as higher rates of hospitalization and less frequent use of preventive services, which leads to higher healthcare costs. This is especially troubling for individuals over the age of 65 because they have low health literacy, live on a fixed budget and Medicare doesn’t pay for all the costs.

Clinical trials have a profound effect on the health and wellbeing of society, often leading to the approval of groundbreaking drugs that cure and prevent maladies.  While clinical research is the gateway to an improved understanding about diseases and treatment, sponsors encounter strong headwinds when administering clinical trials. Recruiting patients to participate in clinical trials is a major challenge, and the trend toward larger clinical trial sizes is only exacerbating the process.